Estramustina [Inn-Spanish]
Estramustina [Inn-Spanish] Brand names, Estramustina [Inn-Spanish] Analogs
Estramustina [Inn-Spanish] Brand Names Mixture
- No information avaliable
Estramustina [Inn-Spanish] Chemical_Formula
C23H31Cl2NO3
Estramustina [Inn-Spanish] RX_link
http://www.rxlist.com/cgi/generic2/estramustine.htm
Estramustina [Inn-Spanish] fda sheet
Estramustina [Inn-Spanish] msds (material safety sheet)
Estramustina [Inn-Spanish] Synthesis Reference
No information avaliable
Estramustina [Inn-Spanish] Molecular Weight
440.403 g/mol
Estramustina [Inn-Spanish] Melting Point
104.5 oC
Estramustina [Inn-Spanish] H2O Solubility
No information avaliable
Estramustina [Inn-Spanish] State
Solid
Estramustina [Inn-Spanish] LogP
4.636
Estramustina [Inn-Spanish] Dosage Forms
Capsule
Estramustina [Inn-Spanish] Indication
For the palliative treatment of patients with metastatic and/or progressive carcinoma of the prostate
Estramustina [Inn-Spanish] Pharmacology
Estramustine is an antineoplastic agent indicated in the palliative treatment of patients with metastatic and/or progressive carcinoma of the prostate. Estramustine is a combination of estradiol with nornitrogen mustard. The precise mechanism of action of estramustine is unknown. Unlike other alkylating agents, estramustine does not directly damage DNA.
Estramustina [Inn-Spanish] Absorption
No information avaliable
Estramustina [Inn-Spanish] side effects and Toxicity
No information avaliable
Estramustina [Inn-Spanish] Patient Information
No information avaliable
Estramustina [Inn-Spanish] Organisms Affected
Humans and other mammals
![Estramustina_[Inn-Spanish]](/images/rx/APRD00625.gif)
